Abstract
Venom mixtures from insects, reptiles, and mollusks have long been a source of bioactive peptides which often have alternative uses as therapeutics. While these molecules act in numerous capacities, there have been many venom components that act on the target cells through membrane disruptive mechanisms. These peptides have long been of interest as potential antimicrobial peptide platforms, but the inherent cytotoxicity of venom peptides often results in poor therapeutic potential. Despite this, efforts are ongoing to identify and characterize venom peptide which exhibit high antimicrobial activity with low cytotoxicity and modify these to further enhance the efficacy while reducing toxicity. One example is ponericin L1 from Neoponera goeldii which has been demonstrated to have good antimicrobial activity and low in vitro cytotoxicity. The L1 sequence was modified by uniformly replacing the native hydrophobic residues with either Leu, Ile, Phe, Ala, or Val. Spectroscopic and microbiological approaches were employed to investigate how the amino acid sequence changes impacted membrane interaction, secondary structure, and antimicrobial efficacy. The L1 derivatives showed varying degrees of bilayer interaction, in some cases driven by bilayer composition. Several of the variants exhibited enhanced antimicrobial activity compared to the parent strain, while others lost all activity. Interestingly, the variant containing Val lost all antimicrobial activity and ability to interact with bilayers. Taken together the results indicate that peptide secondary structure, amino acid composition, and hydrophobicity all play a role in peptide activity, although this is a delicate balance that can result in non-specific binding or complete loss of activity if specific amino acids are incorporated.
Graphic Abstract
Similar content being viewed by others
References
Aili SR, Touchard A, Escoubas P, Padula MP, Orivel J, Dejean A, Nicholson GM (2014) Diversity of peptide toxins from stinging ant venoms. Toxicon 92:166–178
Arenas I, Villegas E, Walls O, Barrios H, Rodríguez R, Corzo G (2016) Antimicrobial activity and stability of short and long based arachnid synthetic peptides in the presence of commercial antibiotics. Molecules 21
Buccini DF, Cardoso MH, Franco OL (2021) Antimicrobial peptides and cell-penetrating peptides for treating intracellular bacterial infections. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2020.612931
Burman LG, Nordstrom K, Boman HG (1968) Resistance of Escherichia coli to penicillins. V. Physiological comparison of two isogenic strains, one with chromosomally and one with episomally mediated ampicillin resistance. J Bacteriol 96:438–446
Caputo GA, London E (2019) Analyzing transmembrane protein and hydrophobic helix topography by dual fluorescence quenching. Methods Mol Biol 2003:351–368
CDC (2019) Antibiotic resistance threats in the United States, 2019. U.S. Department of Health and Human Services, CDC
Chrom CL, Renn LM, Caputo GA (2019) Characterization and antimicrobial activity of amphiphilic peptide AP3 and derivative sequences. Antibiotics 8
Dong N, Ma Q, Shan A, Lv Y, Hu W, Gu Y, Li Y (2012) Strand length-dependent antimicrobial activity and membrane-active mechanism of arginine- and valine-rich beta-hairpin-like antimicrobial peptides. Antimicrob Agents Chemother 56:2994–3003
Edwards IA, Elliott AG, Kavanagh AM, Zuegg J, Blaskovich MAT, Cooper MA (2016) Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides. ACS Infect Dis 2:442–450
Flockton TR, Schnorbus L, Araujo A, Adams J, Hammel M, Perez LJ (2019) Inhibition of pseudomonas aeruginosa biofilm formation with surface modified polymeric nanoparticles. Pathogens 8:55
Foster LL, Yusa S-i, Kuroda K (2019) Solution-mediated modulation of pseudomonas aeruginosa biofilm formation by a cationic synthetic polymer. Antibiotics 8:61
Goderecci SS, Kaiser E, Yanakas M, Norris Z, Scaturro J, Oszust R, Medina CD, Waechter F, Heon M, Krchnavek RR, Yu L, Lofland SE, Demarest RM, Caputo GA, Hettinger JD (2017) Silver oxide coatings with high silver-ion elution rates and characterization of bactericidal activity. Molecules 22
Gottler LM, de la Salud Bea R, Shelburne CE, Ramamoorthy A, Marsh ENG (2008) Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the β-hairpin antimicrobial peptide protegrin-1. Biochemistry 47:9243–9250
Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, Håkansson J, Hansen PR, Svenson J (2020) Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci Rep 10:13206
Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1:2876–2890
Haldar S, Raghuraman H, Chattopadhyay A (2008) Monitoring orientation and dynamics of membrane-bound melittin utilizing dansyl fluorescence. J Phys Chem B 112:14075–14082
Hitchner MA, Necelis MR, Shirley D, Caputo GA (2021) Effect of non-natural hydrophobic amino acids on the efficacy and properties of the antimicrobial peptide C18G. Probiotics Antimicrob Proteins 13:527–541
Hitchner MA, Santiago-Ortiz LE, Necelis MR, Shirley DJ, Palmer TJ, Tarnawsky KE, Vaden TD, Caputo GA (2019) Activity and characterization of a pH-sensitive antimicrobial peptide. Biochim Biophys Acta Biomembr
Johnson SR, Copello JA, Evans MS, Suarez AV (2010) A biochemical characterization of the major peptides from the Venom of the giant Neotropical hunting ant Dinoponera australis. Toxicon 55:702–710
Kraus D (2014) Consolidated data analysis and presentation using an open-source add-in for the Microsoft Excel® spreadsheet software. Med Writ 23:25–28
Kuroda K, Caputo GA, DeGrado WF (2009) The role of hydrophobicity in the antimicrobial and hemolytic activities of polymethacrylate derivatives. Chemistry 15:1123–1133
Ladokhin AS, Selsted ME, White SH (1997) Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys J 72:794–805
Lepore C, Silver L, Theuretzbacher U, Thomas J, Visi D (2019) The small-molecule antibiotics pipeline: 2014–2018. Nat Rev Drug Discov 18:739
Mahlapuu M, Håkansson J, Ringstad L, Björn C (2016) Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol 6:194
Makhlynets OV, Caputo GA (2021) Characteristics and therapeutic applications of antimicrobial peptides. Biophys Rev 2:011301
Manniello MD, Moretta A, Salvia R, Scieuzo C, Lucchetti D, Vogel H, Sgambato A, Falabella P (2021) Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance. Cell Mol Life Sci
Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. Biochimica et Biophysica Acta (BBA) - Biomembranes 1788:1687–1692
Mohamed MF, Abdelkhalek A, Seleem MN (2016) Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus. Sci Rep 6:29707
Mortazavian H, Foster LL, Bhat R, Patel S, Kuroda K (2018) Decoupling the functional roles of cationic and hydrophobic groups in the antimicrobial and hemolytic activities of methacrylate random copolymers. Biomacromol 19:4370–4378
Neil KT, DeGrado WF (1990) A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids. Science 250:646
Nick Pace C, Martin Scholtz J (1998) A helix propensity scale based on experimental studies of peptides and proteins. Biophys J 75:422–427
World Health Organization (2018) Monitoring global progress on addressing antimicrobial resistance (AMR), (ed)^(eds)
Orivel J, Redeker V, Le Caer JP, Krier F, Revol-Junelles AM, Longeon A, Chaffotte A, Dejean A, Rossier J (2001) Ponericins, new antibacterial and insecticidal peptides from the venom of the ant Pachycondyla goeldii. J Biol Chem 276:17823–17829
Palermo EF, Kuroda K (2009) Chemical structure of cationic groups in amphiphilic polymethacrylates modulates the antimicrobial and hemolytic activities. Biomacromol 10:1416–1428
Palermo EF, Kuroda K (2010) Structural determinants of antimicrobial activity in polymers which mimic host defense peptides. Appl Microbiol Biotechnol 87:1605–1615
Palermo EF, Lienkamp K, Gillies ER, Ragogna PJ (2019) Antibacterial activity of polymers: discussions on the nature of amphiphilic balance. Angew Chem Int Ed 58:3690–3693
Raghuraman H, Chattopadhyay A (2006) Effect of ionic strength on folding and aggregation of the hemolytic peptide melittin in solution. Biopolymers 83:111–121
Rani G, Kuroda K, Vemparala S (2020) Aggregation of methacrylate-based ternary biomimetic antimicrobial polymers in solution. J Phys 33:064003
Saint Jean KD, Henderson KD, Chrom CL, Abiuso LE, Renn LM, Caputo GA (2018) Effects of hydrophobic amino acid substitutions on antimicrobial peptide behavior. Probiotics Antimicrob Proteins 10:408–419
Savinov SN, Heuck AP (2017) Interaction of cholesterol with perfringolysin O: what have we learned from functional analysis? Toxins 9
Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T (2017) Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii Infection. Antimicrob Agents Chemother 61:e00954-e1017
Senetra AS, Necelis MR, Caputo GA (2020) Investigation of the structure-activity relationship in ponericin L1 from Neoponera goeldii. Pept Sci 112:e24162
Snider C, Jayasinghe S, Hristova K, White SH (2009) MPEx: a tool for exploring membrane proteins. Protein Sci 18:2624–2628
Sovadinova I, Palermo EF, Huang R, Thoma LM, Kuroda K (2011) Mechanism of polymer-induced hemolysis: nanosized pore formation and osmotic lysis. Biomacromol 12:260–268
Tang J, Signarvic RS, DeGrado WF, Gai F (2007) Role of helix nucleation in the kinetics of binding of mastoparan X to phospholipid bilayers. Biochemistry 46:13856–13863
Vaezi Z, Bortolotti A, Luca V, Perilli G, Mangoni ML, Khosravi-Far R, Bobone S, Stella L (2020) Aggregation determines the selectivity of membrane-active anticancer and antimicrobial peptides: the case of killerFLIP. Biochimica et Biophysica Acta (BBA) - Biomembranes 1862:183107
Wiegand I, Hilpert K, Hancock REW (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3:163–175
Wimley WC, White SH (1996) Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol 3:842–848
Yang J, Zhang Y (2015) I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res 43:W174–W181
Zapadka KL, Becher FJ, Santos ALGd, Jackson SE (2017) Factors affecting the physical stability (aggregation) of peptide therapeutics. Interface Focus 7:20170030
Acknowledgements
The authors are thankful to the Rowan University Pharmaceutical Sciences program for support of NPS. The authors would like to thank Mikhail Anikin at Rowan University School of Osteopathic Medicine for assistance with MALDI mass spectrometry.
Funding
This work was funded in part by the National Institutes of Health Grant NIH R15 GM094330.
Author information
Authors and Affiliations
Contributions
The study was conceptualized by GAC. Experiments were performed by NPS. Data analysis and manuscript preparation was carried out by GAC and NPS.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Schifano, N.P., Caputo, G.A. Investigation of the Role of Hydrophobic Amino Acids on the Structure–Activity Relationship in the Antimicrobial Venom Peptide Ponericin L1. J Membrane Biol 255, 537–551 (2022). https://doi.org/10.1007/s00232-021-00204-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-021-00204-y